Anika Therapeutics, Inc. Amortization of Debt Discount (Premium)
Anika Therapeutics, Inc. (ANIK) reported Amortization of Debt Discount (Premium) of -$25.00 thousand for the 12-month period ending 2020-12-31, per its 10-K/A filed 2021-04-26.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2021-04-26
- Anika Therapeutics, Inc. amortization of debt discount (premium) for fiscal 2020 was -$25.00K.
- Anika Therapeutics, Inc. amortization of debt discount (premium) for fiscal 2019 was $0.00.
- Anika Therapeutics, Inc. amortization of debt discount (premium) for fiscal 2018 was $0.00.
| Period end | Amortization of Debt Discount (Premium) 12 month |
|---|---|
| 2020-12-31 | -$25.00K 10-K/A · filed 2021-04-26 |
| 2019-12-31 | $0.00 10-K/A · filed 2021-04-26 |
| 2018-12-31 | $0.00 10-K/A · filed 2021-04-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |